The University of Western Ontario

Papiez, L., and J.J. Battista. 1995. Radiance and particle fluence. Physics Medical Biology 40: 1731-1732.

Sharpe, M.B., D.A. Jaffray, J.J. Battista, and P.N. Munro. 1995. Extra-focal radiation: a unified approach to the production of beam penumbra and output factors for megavoltage x-ray beams. Medical Physics 22: 2065-2074.

Van Dyk, J., and J.J. Battista. 1996. Cobalt-60: An old modality, a renewed challenge. Current Oncology 3: 8-17.

Bautista, D.S., Z. Saad, A.F. Chambers, K.S. Tonkin, F.P. O'Malley, S. Singhal, S. Tokmakejian, V.H.C. Bramwell, and J.F. Harris. 1996. Quantification of osteopontin in human plasma with an ELISA: basal levels in pre- and postmenopausal women. Clinical Biochemistry 29: 231-239.

Bramwell, V.H.C. 1995. The role of chemotherapy in osteogenic sarcoma. Clinical Reviews in Oncology/Haematology 20: 61-85.

Bramwell, V.H.C., E.A. Eisenhauer, M. Blackstein, G. Boos, Knowling, J. Jolivet, and W. Bogues. 1995. Phase II study of topotecan (NSC 609 699) in patients with recurrent or metastatic soft tissue sarcoma. Annals of Oncology 6: 847-849.

Mertens, W.C., D. Banerjee, N. Al-Mutter, L.W. Stitt, V.H.C. Bramwell, and P.K. Lala. 1995. High dose continuous venous infusion interleukin-2: influence of dose and infusion rate on tumoricidal function, lymphocyte subsets and clinical response. Cancer Immunology and Immunotherapy 41: 271-279.

Mertens, W.C., and V.H.C. Bramwell. 1995. Adjuvant chemotherapy for soft tissue sarcomas. Haematology Clinics of North America 9: 801-815.

Mertens, W.C., and V.H.C. Bramwell. 1995. Osteosarcoma and other tumors of bone. Current Opinion in Oncology 7: 349-354.

Bacchus, J.N., and J.G. Cairncross. 1995. Conservative treatment of low grade glioma. Controversies in Neurosurgery. New York, NY: Thieme Medical Publishers. 55-63.

Cairncross, J.G. 1995. Low grade glioma - the case for delayed surgery. Clinical Neurosurgery, Volume 42. Baltimore, MD: Williams and Wilkins. 391-398.

Forsyth, P.A.J., and J.G. Cairncross. 1995. Treatment of malignant glioma in adults. Current Opinion in Neurology, Volume 8. London, U.K: Current Science. 414-418.

Halperin, E.C., J. Herndon, S.C. Schold, M. Brown, N. Vick, J.G. Cairncross, D.R. Macdonald, L.E.W. Gaspar, E. Dropcho, R. Rosenfeld, R. Morowitz, J. Piepmeier, W. Hait, T. Byrne, M. Salter, J. Imperato, J. Khandekar, P. Burger, G. Gentel, and A. Friedman. 1996. A phase III randomized prospective trial of external beam radiotherapy, Mitomycin C, BCNU and 6-Mercaptopurine for the treatment of adults with anaplastic glioma of the brain. International Journal of Radiation Oncology, Biology, Physics 34: 793-802.

Kirby, A.S., M. Brothers, W. Irish, R. Florell, D.R. Macdonald, S.C. Schold, and J.G. Cairncross. 1995. Evaluating glioma therapies - modeling treatments and predicting outcomes. Journal of the National Cancer Institute 87: 1844-1888.

Kirby, A.S., D.R. Macdonald, B.J. Fisher, L.E.W. Gaspar, and J.G. Cairncross. 1996. Pre-radiation chemotherapy for anaplastic glioma. Canadian Journal of Sciences 23: 123-127.

Macdonald, D.R., J.G. Cairncross, P.A.J. Forsyth, C. Sawka, N. Wainman, E.A. Eisenhauer, and D. Stewart. 1996. Phase II study of topotecan in patients with recurrent malignant glioma. Annals of Oncology 7: 205-207.

Macdonald, D.R., J.G. Cairncross, D. Stewart, P.A.J. Forsyth, C. Sawka, N. Wainman, and E.A. Eisenhauer. 1996. NCIC-CTG phase II study of topotecan in malignant glioma. Journal of NeuroOncology 28: 72.

Nutt, C.L., A.F. Chambers, and J.G. Cairncross. 1996. Wild-type p53 renders mouse astrocytes resistant to 1,3-Bis(2-chloroethyl)-1-nitrosourea despite the absense of a p-53-dependent cell cycle arrest. Cancer Research Advances in Brief 56: 2748-2751.

Peterson, K., and J.G. Cairncross. 1995. Oligodendroglioma. Neurologic Clinics, Volume 13. Philadelphia, PA: W.B. Saunders. 861-873.

Peterson, K., and J.G. Cairncross. 1996. Oligodendroglioma. Cancer Investigation 14 (3): 243-251.

Scott, J.A., N.B. Rewcastle, P. Brasher, J. MacKinnon, N. Hagen, J.G. Cairncross, and P.A.J. Forsyth. 1996. Which GBM patient will be a long-term survivor? A case-controlled, population-based study in southern Alberta. Neurology 46: 181.

Bautista, D.S., J.D. Denstedt, A.F. Chambers, and J.F. Harris. 1996. Low molecular weight variants of osteopontin generated by serine proteinases in urine of patients with kidney stones. Journal of Cellular Biochemistry 61: 402-409.

Bautista, D.S., Z. Saad, A.F. Chambers, K.S. Tonkin, F.P. O'Malley, S. Singhal, S. Tokmakejian, V.H.C. Bramwell, and J.F. Harris. 1996. Quantification of osteopontin in human plasma with an ELISA: basal levels in pre- and postmenopausal women. Clinical Biochemistry 29: 231-239.

Bautista, D.S., J.W. Xuan, C. Hota, A.F. Chambers, and J.F. Harris. 1996. A monoclonal antibody against osteopontin inhibits RGD-mediated cell adhesion to osteopontin. Annals of the New York Academy of Sciences 760: 309-311.

Behrend, E.I., A.M. Craig, S.M. Wilson, D.T. Denhardt, and A.F. Chambers. 1995. Expression of antisense osteopontin RNA in metastatic mouse fibroblasts is associated with reduced malignancy. Annals of the New York Academy of Sciences 760: 299-301.

Carroll, K.K., N. Guthrie, K. Nesaretnam, A. Gapor, and A.F. Chambers. 1995. Anti-Cancer Properties of Tocotrienols from Palm Oil. Nutrition, Lipids, Health and Disease. Champaign, Illinois: AOCS Press. 117-121.

Chambers, A.F., I.C. MacDonald, E.E. Schmidt, S. Koop, V.L. Morris, R. Khokha, and A.C. Groom. 1995. Steps in tumor metastasis: new concepts from intravital videomicroscopy. Cancer and Metastasis Reviews 14: 279-301.

Hangan, D.A., S. Uniyal, V.L. Morris, I.C. MacDonald, T. vonBallestrem, T. Chau, E.E. Schmidt, A.F. Chambers, A.C. Groom, and B.M.C. Chan. 1996. Integrin VLA-2 (a2B1) function in post-extravasation movement of human rhabdomyosarcoma RD cells in the liver. Cancer Research 56: 3142-3149.

Liaw, L., V. Lindner, S.M. Schwartz, A.F. Chambers, and C.M. Giachelli. 1995. Osteopontin and B3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp-dependent endothelial migration in vitro. Circulation Research 77: 665-672.

Nesaretnam, K., N. Guthrie, A.F. Chambers, and K.K. Carroll. 1995. Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids 12: 1139-1143.

Nutt, C.L., A.F. Chambers, and J.G. Cairncross. 1996. Wild-type p53 renders mouse astrocytes resistant to 1,3-Bis(2-chloroethyl)-1-nitrosourea despite the absense of a p-53-dependent cell cycle arrest. Cancer Research Advances in Brief 56: 2748-2751.

So, F.V., N. Guthrie, A.F. Chambers, M. Moussa, and K.K. Carroll. 1996. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutrition and Cancer 26: 167-181.

Xuan, J.W., J.L. Chin, Y.Z. Guo, A.F. Chambers, M.A. Finkelman, and M.W. Clarke. 1995. Alternative splicing of PSP94 (prostatic secretory protein of 94 amino acids) mRNA in prostate tissue. Oncogene 11: 1041-1047.

Xuan, J.W., S.M. Wilson, J.L. Chin, and A.F. Chambers. 1995. Metastatic NIH 3T3 X LTA cell hybrids express 72 kDa type IV collagenase. Anticancer Research 15: 1227-1234.

Koropatnick, D.J., D.M. Kloth, S. Kadhim, J.L. Chin, and G.M. Cherian. 1995. Metallothionein expression and resistance to cisplatinum in the T7800 human germ cell tumout cell line. Journal of Pharmaceutical and Experimental Therapeutics 275: 1681-1687.

Xuan, J.W., J.L. Chin, Y.Z. Guo, A.F. Chambers, M.A. Finkelman, and M.W. Clarke. 1995. Alternative splicing of PSP94 (prostatic secretory protein of 94 amino acids) mRNA in prostate tissue. Oncogene 11: 1041-1047.

Xuan, J.W., S.M. Wilson, J.L. Chin, and A.F. Chambers. 1995. Metastatic NIH 3T3 X LTA cell hybrids express 72 kDa type IV collagenase. Anticancer Research 15: 1227-1234.

Cooke, A.L., F.E. Perera, B.J. Fisher, A. Opeitum, and N. Yu. 1995. Tamoxifen with and without radiation after partial mastectomy in patients with involved nodes and positive estrogen receptior. International Journal of Radiation Oncology, Biology, Physics 41 (4): 778-781.

Kirby, A.S., D.R. Macdonald, B.J. Fisher, L.E.W. Gaspar, and J.G. Cairncross. 1996. Pre-radiation chemotherapy for anaplastic glioma. Canadian Journal of Sciences 23: 123-127.

Bautista, D.S., J.D. Denstedt, A.F. Chambers, and J.F. Harris. 1996. Low molecular weight variants of osteopontin generated by serine proteinases in urine of patients with kidney stones. Journal of Cellular Biochemistry 61: 402-409.

Bautista, D.S., Z. Saad, A.F. Chambers, K.S. Tonkin, F.P. O'Malley, S. Singhal, S. Tokmakejian, V.H.C. Bramwell, and J.F. Harris. 1996. Quantification of osteopontin in human plasma with an ELISA: basal levels in pre- and postmenopausal women. Clinical Biochemistry 29: 231-239.

Bautista, D.S., J.W. Xuan, C. Hota, A.F. Chambers, and J.F. Harris. 1996. A monoclonal antibody against osteopontin inhibits RGD-mediated cell adhesion to osteopontin. Annals of the New York Academy of Sciences 760: 309-311.

Chambers, A.F., I.C. MacDonald, E.E. Schmidt, S. Koop, V.L. Morris, R. Khokha, and A.C. Groom. 1995. Steps in tumor metastasis: new concepts from intravital videomicroscopy. Cancer and Metastasis Reviews 14: 279-301.

Sanchez-Sweatman, O.H., R. Khokha, and F.W. Orr. 1996. Mechanisms of cancer cell-mediated osteolysis (Chapter 8). Bone Metastasis - Mechanisms and Pathophysiology. F.W. Orr, and G. Singh. New York, NY: R.G. Landes Company. 123-136.

Kocha, W.I. 1995. Phase III randomized study of two Fluorouricil combinations with either Interferon alfa-2a or Leucovorin for advanced colorectal cancer. Journal of Clinical Oncology 13: 921-928.

Koropatnick, D.J., D.M. Kloth, S. Kadhim, J.L. Chin, and G.M. Cherian. 1995. Metallothionein expression and resistance to cisplatinum in the T7800 human germ cell tumout cell line. Journal of Pharmaceutical and Experimental Therapeutics 275: 1681-1687.

Mertens, W.C., D. Banerjee, N. Al-Mutter, L.W. Stitt, V.H.C. Bramwell, and P.K. Lala. 1995. High dose continuous venous infusion interleukin-2: influence of dose and infusion rate on tumoricidal function, lymphocyte subsets and clinical response. Cancer Immunology and Immunotherapy 41: 271-279.

Levin, L. 1995. Chemotherapy options in ovarian carcinoma - a dose intensity perspective. Ovarian Cancer. 3rd ed. London, U.K: Chapman and Hall Medical. 195-201.

Chen, R., D.R. Macdonald, and D.A. Ramsay. 1995. Primary diffuse leptomeningeal oligodendroglioma. Journal of Neurosurgery 83: 724-728.

Halperin, E.C., J. Herndon, S.C. Schold, M. Brown, N. Vick, J.G. Cairncross, D.R. Macdonald, L.E.W. Gaspar, E. Dropcho, R. Rosenfeld, R. Morowitz, J. Piepmeier, W. Hait, T. Byrne, M. Salter, J. Imperato, J. Khandekar, P. Burger, G. Gentel, and A. Friedman. 1996. A phase III randomized prospective trial of external beam radiotherapy, Mitomycin C, BCNU and 6-Mercaptopurine for the treatment of adults with anaplastic glioma of the brain. International Journal of Radiation Oncology, Biology, Physics 34: 793-802.

Kirby, A.S., M. Brothers, W. Irish, R. Florell, D.R. Macdonald, S.C. Schold, and J.G. Cairncross. 1995. Evaluating glioma therapies - modeling treatments and predicting outcomes. Journal of the National Cancer Institute 87: 1844-1888.

Kirby, A.S., D.R. Macdonald, B.J. Fisher, L.E.W. Gaspar, and J.G. Cairncross. 1996. Pre-radiation chemotherapy for anaplastic glioma. Canadian Journal of Sciences 23: 123-127.

Macdonald, D.R., J.G. Cairncross, P.A.J. Forsyth, C. Sawka, N. Wainman, E.A. Eisenhauer, and D. Stewart. 1996. Phase II study of topotecan in patients with recurrent malignant glioma. Annals of Oncology 7: 205-207.

Macdonald, D.R., J.G. Cairncross, D. Stewart, P.A.J. Forsyth, C. Sawka, N. Wainman, and E.A. Eisenhauer. 1996. NCIC-CTG phase II study of topotecan in malignant glioma. Journal of NeuroOncology 28: 72.

Ramsay, D.A., J. Bonnin, D.R. Macdonald, and L.J. Assis. 1995. Medulloblastomas in late middle age and the elderly: report of two cases. Clinical Neuropathology 14: 337-342.

Chambers, A.F., I.C. MacDonald, E.E. Schmidt, S. Koop, V.L. Morris, R. Khokha, and A.C. Groom. 1995. Steps in tumor metastasis: new concepts from intravital videomicroscopy. Cancer and Metastasis Reviews 14: 279-301.

Hangan, D.A., S. Uniyal, V.L. Morris, I.C. MacDonald, T. vonBallestrem, T. Chau, E.E. Schmidt, A.F. Chambers, A.C. Groom, and B.M.C. Chan. 1996. Integrin VLA-2 (a2B1) function in post-extravasation movement of human rhabdomyosarcoma RD cells in the liver. Cancer Research 56: 3142-3149.

Bissonnette, J.P., and P.N. Munro. 1996. Evaluation of a high density scintillating glass detector for portal imaging. Medical Physics 23: 401-405.

Meeder, R.J.J., D.A. Jaffray, and P.N. Munro. 1995. Tests for evaluating laser film digitizers. Medical Physics 22: 635-642.

Sharpe, M.B., D.A. Jaffray, J.J. Battista, and P.N. Munro. 1995. Extra-focal radiation: a unified approach to the production of beam penumbra and output factors for megavoltage x-ray beams. Medical Physics 22: 2065-2074.

Bautista, D.S., Z. Saad, A.F. Chambers, K.S. Tonkin, F.P. O'Malley, S. Singhal, S. Tokmakejian, V.H.C. Bramwell, and J.F. Harris. 1996. Quantification of osteopontin in human plasma with an ELISA: basal levels in pre- and postmenopausal women. Clinical Biochemistry 29: 231-239.

Cooke, A.L., F.E. Perera, B.J. Fisher, A. Opeitum, and N. Yu. 1995. Tamoxifen with and without radiation after partial mastectomy in patients with involved nodes and positive estrogen receptior. International Journal of Radiation Oncology, Biology, Physics 41 (4): 778-781.

Taylor, M.J. 1995. Management options for familial cancer syndromes. Canadian Journal of Continuing Medical Education 7: 4.

Bautista, D.S., Z. Saad, A.F. Chambers, K.S. Tonkin, F.P. O'Malley, S. Singhal, S. Tokmakejian, V.H.C. Bramwell, and J.F. Harris. 1996. Quantification of osteopontin in human plasma with an ELISA: basal levels in pre- and postmenopausal women. Clinical Biochemistry 29: 231-239.

Islam, M.K., and J. Van Dyk. 1995. Effects of scatter generated by beam modifying absorbers in megavoltage photon beams. Medical Physics 22: 2075-2081.

Van Dyk, J., and J.J. Battista. 1996. Cobalt-60: An old modality, a renewed challenge. Current Oncology 3: 8-17.

Trudeau, M.E., E.A. Eisenhauer, B.P. Higgins, F. Letendre, W.S. Lofters, B.D. Norris, T.A. Vandenberg, F. Delorme, and A. Muldal. 1996. Docetaxel in patients with metastatic breast cancer: a Phase II study of the NCIC Clinical Trials Group. Journal of Clinical Oncology 14: 422-428.

Vandenberg, T.A., D. Gustafson, and S. Markland. 1996. A randomized prospective pilot study to evaluate the effect of computer-based information and support for women with newly diagnosed breast cancer. Supportive Care Journal 4: 239-240.

Yee, S.P. 1996. Transgenic Animals (Chapter 20). Methods in Renal Toxicology. R.K. Zalups, and L.H. Lash. Boca Raton, FL: CRC Press. 413-426.